Publications by authors named "Jose M Fernandez Navarro"

Hyperleukocytosis in pediatric acute myeloid leukemia (AML) is associated with severe complications and an inferior outcome. We report results on patients with hyperleukocytosis included in the NOPHO-DBH AML 2012 study. We recommended immediate initiation of full-dose chemotherapy (etoposide monotherapy for 5 days as part of the first course), avoiding leukapheresis and prephase chemotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • * Three new recurring KMT2A-rearranged groups were identified, and a significant variation in 5-year event-free survival rates was observed across 13 different groups, highlighting the impact of genetic factors on patient outcomes.
  • * The research suggests incorporating five specific adverse-risk KMT2A fusions into current risk stratification models and calls for further studies to confirm the associations
View Article and Find Full Text PDF

Purpose: Measurable residual disease (MRD) by using flow cytometry after induction therapy is strongly prognostic in pediatric AML, and hematopoietic stem-cell transplant (hSCT) may counteract a poor response. We designed a phase III study with intensified response-guided induction and MRD-based risk stratification and treated poor induction response with hSCT. The efficacy of liposomal daunorubicin (DNX) in induction was compared with mitoxantrone.

View Article and Find Full Text PDF

Transplantation-associated thrombotic microangiopathy (TA-TMA) is associated with high morbidity and mortality. Although survival has improved significantly with the introduction of eculizumab, the need for improvement remains, especially in high-risk patients. This study aimed to describe the results obtained with eculizumab in a pediatric cohort with the attempt to define which risk factors could determine the response to treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Hematopoietic stem cell transplantation (HCT) is an effective treatment for chronic granulomatous disease (CGD) in children, but it carries risks of complications and varying benefits depending on donor type.
  • A study of 30 pediatric patients showed a graft failure rate of 28.26% and chronic graft-versus-host disease (GVHD) in 20.5%, with higher risks for those who received transplants from unrelated donors compared to sibling donors.
  • Overall, the 2-year overall survival rate was 77.3%, but careful consideration of donor type and post-transplant care is crucial due to the potential for significant morbidity and mortality.
View Article and Find Full Text PDF

Increasing data on treosulfan-based conditioning regimens before hematopoietic stem cell transplantation (HSCT) demonstrate the consistent benefits of this approach, particularly regarding acute toxicity. This study aimed to describe the results of treosulfan-based conditioning regimens in children, focusing on toxicity and outcomes when used to treat both malignant and nonmalignant diseases. This retrospective observational study of pediatric patients treated in Spain with treosulfan-based conditioning regimens before HSCT was based on data collection from electronic clinical records.

View Article and Find Full Text PDF
Article Synopsis
  • A study by the I-BFM-SG on childhood rearranged acute myeloid leukemia (AML) revealed that the type of fusion partner plays a significant role in prognosis, and it also explored the effectiveness of flow cytometry-based measurable residual disease (flow-MRD) and allogeneic stem-cell transplantation (allo-SCT) in improving outcomes during first complete remission.
  • The research involved 1,130 children diagnosed with rearranged AML, who were categorized into high-risk and non-high-risk groups based on their fusion partners, and it focused on the relationship between flow-MRD levels and long-term survival rates.
  • Results showed that the high-risk group had significantly worse event-free survival, cumulative incidence of relapse, and overall survival
View Article and Find Full Text PDF

Introduction: Pediatric acute myeloid leukemia (AML) is the second most common type of pediatric leukemia. Patients with AML are at high risk for several complications such as infections, typhlitis, and acute and long-term cardiotoxicity. Despite this knowledge, there are no definite supportive care guidelines as to what the best approach is to manage or prevent these complications.

View Article and Find Full Text PDF

Introduction: Graft-vs-host disease (GVHD) is a frequent cause of morbidity and mortality in allogeneic stem cell transplants. Extracorporeal photopheresis (ECP) is one of the most accepted second-line treatments, but technical issues of ECP in children might be prohibitive.

Materials And Methods: Patients under 18 y of age with corticodependant or corticorefractory GVHD receiving ECP at our hospital were included in this retrospective study.

View Article and Find Full Text PDF

A total of 192 pediatric patients, median age 8.6 years, with high-risk hematological malignancies, underwent haploidentical stem cell transplantation (haplo-HSCT) using post-transplantation cyclophosphamide (PT-Cy), or ex vivo T cell-depleted (TCD) graft platforms, from January 1999 to December 2016 in 10 centers in Spain. Some 41 patients received an unmanipulated graft followed by PT-Cy for graft-vs-host disease (GvHD) prophylaxis.

View Article and Find Full Text PDF

Objective: To study the incidence, risk factors, and treatment of hemorrhagic cystitis secondary to BK-virus reactivation (HC-BKV) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the pediatric population.

Methods: Case-control study in which all pediatric patients (0-18 years) who underwent allo-HSCT from September 2009 to January 2014 were followed.

Results: Twenty-nine patients underwent an allo-HSCT.

View Article and Find Full Text PDF

There are concerns of a reduced effect of liposomal amphotericin B (L-AmB) given sequentially after mold-active azoles due to a possible antagonism in their antifungal mechanism. To investigate this possible effect in the clinic, we retrospectively studied 182 high risk hematologic patients with invasive fungal infections (IFI) who were treated with L-AmB. Overall, 96 patients (52.

View Article and Find Full Text PDF

Cytarabine (1000 mg/m/d intravenous for 5 d) and clofarabine (40 mg/m/d intravenous for 5 d) were given every 28 days to 9 children with relapsed acute myeloid leukemia at our institution. Among 19 courses, there were 18 infectious episodes. Median hospitalization time was 13 days (7.

View Article and Find Full Text PDF

In this work, we report the optical properties of Tm(3+) ions in tellurite glasses (TeO(2)-TiO(2)-Nb(2)O(5)) for different Tm(3+) concentrations ranging between 0.05 and 1 wt%. Judd-Ofelt intensity parameters have been determined to calculate the radiative transition probabilities and radiative lifetimes of excited states.

View Article and Find Full Text PDF

Standard cytomorphological examination of bone marrow (BM) aspirates does not appear to be sensitive enough to detect single neuroblastoma cells. The SIOPEN Neuroblastoma Bone Marrow Committee developed a sensitive and reproducible anti-GD2 immunocytochemical assay and introduced morphological and immunocytological criteria for the interpretation of results. Fixed cytospins were incubated with a commercially available anti-GD2 monoclonal antibody and an APAAP kit.

View Article and Find Full Text PDF